DaVita (DVA)

NYSE Health Care Health Care Services S&P 500
$191.35
-3.47 (-1.78%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Trailing 12-month EPS
$13.51
Diluted, last four reported quarters

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Oct 29, 2026Sep/2026$3.78$3.82+1.1%

Our record of DVA's reports since we began tracking; it grows each quarter.

Latest results, in brief

All DVA 8-K briefs →
Oct 29, 4:06 PM ET

DaVita Reports Third Quarter 2026 Results and Updates Full-Year Outlook

Mixed earnings 2.02

DaVita Inc. announced consolidated revenues of $3.578 billion and diluted earnings per share of $3.40 for the third quarter ended September 30, 2026. The company also updated its full-year 2026 guidance ranges for adjusted operating income and adjusted diluted earnings per share.

  • Consolidated revenues for Q3 2026 were $3.578 billion with an operating income of $499 million.
  • Diluted earnings per share was $3.40 and adjusted diluted earnings per share was $3.82 for the quarter ended September 30, 2026.
  • The company repurchased 0.6 million shares for $111 million during the third quarter of 2026 at an average price of $186.21 per share.
  • Updated 2026 guidance projects adjusted operating income between $2.175 billion and $2.250 billion.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$3.58B+4.6% $3.40+66.7% $222.93M6.2%
Jun 2026$3.55B+5.2% $4.02+55.8% $265.40M7.5%
Mar 2026$3.42B+6.0% $2.87+43.5% $197.53M5.8%
Dec 2025$3.62B+9.9% $3.22+4.9% $234.22M6.5%
Sep 2025$3.42B+4.8% $2.04-18.4% $150.33M4.4%
Jun 2025$3.38B+6.1% $2.58+3.2% $199.34M5.9%
Mar 2025$3.22B+5.0% $2.00-24.5% $162.92M5.1%
Dec 2024$3.29B+4.7% $3.07+89.5% $259.33M7.9%

From DaVita's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$13.64B+6.5% $9.84-8.3%5.5%
FY2024$12.82B+5.6% $10.73+44.6%7.3%
FY2023$12.14B+4.6% $7.42+26.8%5.7%
FY2022$11.61B-0.1% $5.85-34.3%4.8%
FY2021$11.62B+0.6% $8.90+41.0%8.4%

Frequently asked questions

When is DaVita's next earnings date?

DaVita has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did DaVita earn last quarter?

For the quarter ended Sep 2026, DaVita reported diluted EPS of $3.40 (+66.7% year over year) on revenue of $3.58B (+4.6%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.